Tranexamic Acid Tablet, Film Coated
Product Images NDC 0591-3720

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 0591-3720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tranexamic Acid Tablets A202093 1

FDA Label Image

Tranexamic Acid Tablets A202093 2

This appears to be a table showing the Mean Menstrual Blood Loss (in milliliters) for different treatment periods (Baseline, Cycle 1, Cycle 2, etc.) and different treatments (Tranexamic Acid Tablets 3300mg/day, Placebo, Tranexamic Acid Tablets 3900mg/day, Placebo) for a study related to menstrual bleeding.*

FDA Label Image

Tranexamic Acid Tablets A202093 3

This is a description of medication packaging - Tranexamic Acid Tablets containing 650mg each. It provides storage instructions and a cautionary note in regards to temperature. The manufacturer's name, Teva, is mentioned along with a product code and a unique identification number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.